논문정보 : Koo BS, Lim YC, Lee MY, Jeon JY, Yoo HJ, Oh IS, et al. Dose Reduction of Tumor Necrosis Factor Inhibitor and its Effect on Medical Costs for Patients with Ankylosing Spondylitis. Rheumatol Ther. 2021;8(1):347-59.
논문정보 : Lee EK, Malone DC. Comparison of peptic-ulcer drug use and expenditures before and after the implementation of a government policy to separate prescribing and dispensing practices in South Korea. Clin Ther. 2003;25(2):578-92.
논문정보 : Bae EY, Lee EK. Pharmacoeconomic guidelines and their implementation in the positive list system in South Korea. Value Health. 2009;12 Suppl 3:S36-41.
논문정보 : Bae JY, Kim CH, Lee EK. Evaluation of cost-utility of varenicline compared with existing smoking cessation therapies in South Korea. Value Health. 2009;12 Suppl 3:S70-3.
논문정보 : Ha D, Choi Y, Kim DU, Chung KH, Lee EK. A comparative analysis of the impact of a positive list system on new chemical entity drugs and incrementally modified drugs in South Korea. Clin Ther. 2011;33(7):926-32.
논문정보 : Kwon JM, Cho SK, Kim JH, Lee EK. Medical costs for Korean patients with rheumatoid arthritis based on the national claims database. Rheumatol Int. 2012;32(9):2893-9.
논문정보 : Kwon JM, Rhee J, Ku H, Lee EK. Socioeconomic and employment status of patients with rheumatoid arthritis in Korea. Epidemiol Health. 2012;34:e2012003.
논문정보 : Lee EK, Kim BY, Lim JY, Park MH. Different policy outcomes of the new drugs and currently listed drugs under the positive list system in South Korea. Value Health. 2012;15(1 Suppl):S100-3.
논문정보 : Lee EK, Revil C, Ngoh CA, Lister J, Kwon JM, Park MH, et al. Clinical and cost effectiveness of bevacizumab + FOLFIRI combination versus FOLFIRI alone as first-line treatment of metastatic colorectal cancer in South Korea. Clin Ther. 2012;34(6):1408-19.
논문정보 : Koo BS, Lim YC, Lee MY, Jeon JY, Yoo HJ, Oh IS, et al. Dose Reduction of Tumor Necrosis Factor Inhibitor and its Effect on Medical Costs for Patients with Ankylosing Spondylitis. Rheumatol Ther. 2021;8(1):347-59.
논문보기 : 10.1007/s40744-020-00274-9
논문정보 : Lee EK, Malone DC. Comparison of peptic-ulcer drug use and expenditures before and after the implementation of a government policy to separate prescribing and dispensing practices in South Korea. Clin Ther. 2003;25(2):578-92.
논문보기 : 10.1016/s0149-2918(03)80098-x
논문정보 : Bae EY, Lee EK. Pharmacoeconomic guidelines and their implementation in the positive list system in South Korea. Value Health. 2009;12 Suppl 3:S36-41.
논문보기 : 10.1111/j.1524-4733.2009.00625.x
논문정보 : Bae JY, Kim CH, Lee EK. Evaluation of cost-utility of varenicline compared with existing smoking cessation therapies in South Korea. Value Health. 2009;12 Suppl 3:S70-3.
논문보기 : 10.1111/j.1524-4733.2009.00631.x
논문정보 : Ha D, Choi Y, Kim DU, Chung KH, Lee EK. A comparative analysis of the impact of a positive list system on new chemical entity drugs and incrementally modified drugs in South Korea. Clin Ther. 2011;33(7):926-32.
논문보기 : 10.1016/j.clinthera.2011.05.089
논문정보 : Mo YH, Rhee J, Lee EK. Effects of nutrition support team services on outcomes in ICU patients. Yakugaku Zasshi. 2011;131(12):1827-33.
논문보기 : 10.1248/yakushi.131.1827
논문정보 : Kwon JM, Cho SK, Kim JH, Lee EK. Medical costs for Korean patients with rheumatoid arthritis based on the national claims database. Rheumatol Int. 2012;32(9):2893-9.
논문보기 : 10.1007/s00296-011-2117-2
논문정보 : Kwon JM, Rhee J, Ku H, Lee EK. Socioeconomic and employment status of patients with rheumatoid arthritis in Korea. Epidemiol Health. 2012;34:e2012003.
논문보기 : 10.4178/epih/e2012003
논문정보 : Lee EK, Kim BY, Lim JY, Park MH. Different policy outcomes of the new drugs and currently listed drugs under the positive list system in South Korea. Value Health. 2012;15(1 Suppl):S100-3.
논문보기 : 10.1016/j.jval.2011.11.017
논문정보 : Lee EK, Revil C, Ngoh CA, Lister J, Kwon JM, Park MH, et al. Clinical and cost effectiveness of bevacizumab + FOLFIRI combination versus FOLFIRI alone as first-line treatment of metastatic colorectal cancer in South Korea. Clin Ther. 2012;34(6):1408-19.
논문보기 : 10.1016/j.clinthera.2012.05.001